Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.
about
Long non-coding RNAs as novel targets for therapy in hepatocellular carcinomaLong noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanismThe Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung AdenocarcinomaExpression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb PathwayBasic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesisEpigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone.LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.Long noncoding RNA in liver diseases.Long non-coding RNAs and hepatocellular carcinomaLong non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinomaNoncoding RNA as therapeutic targets for hepatocellular carcinoma.HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus.Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival.EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transitionTransposable Elements in Human Cancer: Causes and Consequences of DeregulationHepatic Long Intergenic Noncoding RNAs: High Promoter Conservation and Dynamic, Sex-Dependent Transcriptional Regulation by Growth Hormone.Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagyGenomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes.Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expressionNeighborhood and Family Environment of Expectant Mothers May Influence Prenatal Programming of Adult Cancer Risk: Discussion and an Illustrative DNA Methylation Example.Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver.Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancerNon-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.Genome-wide histone state profiling of fibroblasts from the opossum, Monodelphis domestica, identifies the first marsupial-specific imprinted gene.LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2.Long noncoding RNAs in liver cancer: what we know in 2014.Focusing on long noncoding RNA dysregulation in gastric cancer.Non-Coding RNAs in Primary Liver Cancer.The cross talk between long, non-coding RNAs and microRNAs in gastric cancer.MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.Long non-coding RNA MEG3 inhibits adipogenesis and promotes osteogenesis of human adipose-derived mesenchymal stem cells via miR-140-5p.Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors.Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implicationsDownregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer.
P2860
Q26751346-EFDEF49F-CF58-4AC1-8E7B-F62ACAE46647Q26775818-8C8FA0B2-0610-475B-A127-6180162183BCQ28547372-E16455C7-2AB7-4E67-9FC0-6DB363F3383DQ28553467-1B296AE8-3428-49E8-AA4B-1AEDAFBCEDBAQ28660994-BC7E0E48-04A6-4E0A-BE4A-CAA463E0A697Q33913401-179B0412-9A0C-4D01-804F-97EA1B835303Q33926034-42CEAC71-68B3-4248-95F1-424AC54D6B4BQ33946469-FFD1638C-827B-4C0F-B7A1-8DA5780ACA9CQ34607635-98B9038E-C4C0-4F6C-A00B-435C362F48F2Q35010490-87B00586-6101-4C52-A6B8-95EABC3A0F7EQ35142587-FBFA6F70-C335-423A-97B0-DECC21A14547Q35592207-32BAA6C0-A043-4C2C-B05D-2AED8E9B6CD1Q35763168-4BCDD0F2-DBF1-464B-8B82-D7C9DE65E84FQ35809876-7E4643D2-D5ED-48A8-B426-2D8691454496Q36179615-759F2876-D8CF-49E3-B17C-A648740A2E8AQ36362814-E4437D3A-26BC-4C57-8023-B2A5C84827ECQ36434022-071C5702-6AE0-40DA-A816-477994352E16Q36499296-1CFCB305-6A7C-4AD5-A866-15351518A83AQ36689117-2FF7E91D-2605-4C91-BB97-FB92029B2EB8Q36722246-6D3FF821-5B48-49BB-9F29-4F503BA0C8C1Q36852725-86C34C1E-3E35-4D1E-8A1A-828C4CFD2C51Q36909743-5AE879E5-3B06-45FC-928C-142809FB1D72Q36935052-9E2FBC84-8A2B-4DBF-A0E2-F1D381D3F3C7Q37358612-C83449D6-041A-4666-A2F3-649916B8B51EQ37550517-BD4E57CA-A7A9-452D-ACBD-B78F65169CB0Q38176848-7468DDC9-5598-4DAC-B587-9EA55CBFB96FQ38241983-5EF69A56-AB4B-454B-B9C3-2EF880088430Q38287045-FD3DDD11-EBDA-44D9-B61B-BD40A5D72AA3Q38541359-A5F27AB8-32EB-4A22-BA56-5ACD76D22E84Q38654296-5DE1E1CF-CD62-4B73-B4B2-DC556155544CQ38847315-2C240FD1-24E8-4028-8286-A91C9F48BEF7Q38914926-8942490C-3DE2-4AF8-8264-FBA0A337D299Q38994050-0EA139EF-B139-47C6-BEC8-7A3B6E8C6606Q40459127-0C935E75-F27C-4F4C-B7BF-C8151C971A8FQ41054929-403B29D6-CE05-49DE-AB15-E9BB84CFCEAAQ41536811-AD457BC7-CE6E-4F65-AB8F-105BD4569AA7Q41608473-E35E97F0-C47D-4888-AC48-CACA4DB10BB8Q45903254-74BA6F22-64C5-4747-8F9B-51A2C9146C9DQ47393672-3B26CB97-B0BA-448E-85ED-78D91F0C9F7BQ47830977-EDBFDA8F-2DFB-4EA6-9BDF-D071F5CE1025
P2860
Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@ast
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@en
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@nl
type
label
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@ast
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@en
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@nl
prefLabel
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@ast
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@en
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Loss of imprinting and allelic ...... uman hepatocellular carcinoma.
@en
P2093
Arndt Vogel
Britta Hasemeier
Elisa Schipper
Hans Kreipe
Nora Schweitzer
Till Krech
Ulrich Lehmann
P2860
P304
P356
10.1371/JOURNAL.PONE.0049462
P407
P577
2012-11-08T00:00:00Z